There is growing evidence supporting the role of peripheral immunity in PD patients, including more rapid PD progression in the presence of a pro-inflammatory cytokine profile in the blood [76], a Th1-biased CD4+ T cell profile [77,78], and an altered CD8+ T cell profile, with increased activation and reduced senescence markers [79]. This evidence concerns the gene CD4 and Parkinson disease.